Psyence BioMed Establishes Texas Entity To Advance U.S. Ibogaine Development

Psyence BioMed (PBM) established Texas Ibogaine Research Corporation (TIRC) as its dedicated U.S. vehicle for regulated ibogaine development. TIRC will coordinate pharmaceutical-grade supply, licensing, manufacturing, regulatory engagement and potential clinical activities.